Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Shockwave Medical, Inc. manufactures medical devices. The Company offers intravascular devices and balloon dilatation catheters for patients with calcified cardiovascular disease. Shockwave Medical serves customers worldwide.
Website: shockwavemedical.com



Growth: Good revenue growth rate 36.0%, there is slowdown compared to average historical growth rates 110.2%. The revenue growth dynamics is stable

Profitability: LTM EBITDA margin is positive, +21.7%. On average the margin is decreasing unsteadily. Gross margin is high, +87.1%. In the last quarter the company beat the estimated EPS, +27.2%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.73 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -0.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 107.9% higher than minimum and 94.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 7.1x by EV / Sales multiple , the company can be 48.1% overvalued

Key Financials (Download financials)

Ticker: SWAV
Share price, USD:  (0.0%)334.75
year average price 334.75  


year start price 334.75 2025-02-14

max close price 334.75 2025-02-14

min close price 334.75 2025-02-14

current price 334.75 2026-02-14
Common stocks: 33 088 095

Dividend Yield:  0.0%
FCF Yield LTM: -0.2%
EV / LTM EBITDA: 63.3x
EV / EBITDA annualized: 61.5x
Last revenue growth (y/y):  +36.0%
Last growth of EBITDA (y/y):  +7.3%
Historical revenue growth:  +110.2%
Historical growth of EBITDA:  +127.2%
EV / Sales: 13.7x
Margin (EBITDA LTM / Revenue): 21.7%
Fundamental value created in LTM:
Market Cap ($m): 11 076
Net Debt ($m): -252
EV (Enterprise Value): 10 824
Price to Book: 14.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-29prnewswire.com

Sarepta Therapeutics Set to Join S&P MidCap 400

2024-05-07Zacks Investment Research

Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y

2024-05-06Zacks Investment Research

Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

2024-05-06Zacks Investment Research

Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates

2024-05-06Zacks Investment Research

Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release

2024-04-25Zacks Investment Research

Why the Market Dipped But Shockwave Medical (SWAV) Gained Today

2024-04-19Zacks Investment Research

Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors

2024-04-15Zacks Investment Research

Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again

2024-04-09Zacks Investment Research

Shockwave Medical's (SWAV) Reducer Receives Positive Results

2024-04-01Zacks Investment Research

Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-05-06 2023-11-06 2023-08-07 2023-05-08 2022-11-07
acceptedDate 2024-05-06 16:14:44 2024-02-26 16:06:34 2023-11-06 16:32:34 2023-08-07 16:46:48 2023-05-08 16:31:28 2023-02-27 16:08:45 2022-11-07 16:48:45 2022-02-25 16:09:03 2021-02-26 16:05:53 2020-03-12 17:02:00
calendarYear 2024 2023 2023 2023 2022
period Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
revenue 219M 730M 186M 180M 161M 490M 131M 237M 68M 43M
costOfRevenue 28M 95M 25M 24M 21M 65M 18M 41M 21M 17M
grossProfit 191M 635M 162M 156M 140M 425M 113M 196M 47M 26M
grossProfitRatio 0.871 0.868 0.864 0.869 0.864
researchAndDevelopmentExpenses 44M 146M 40M 37M 27M 82M 20M 51M 37M 33M
generalAndAdministrativeExpenses 29M 95M 21M 30M 19M 57M 14M 35M 24M 14M
sellingAndMarketingExpenses 74M 235M 57M 57M 54M 162M 42M 111M 52M 31M
sellingGeneralAndAdministrativeExpenses 104M 330M 78M 86M 73M 219M 57M 146M 76M 45M
otherExpenses 0 24M 5M 2M 2M 1M 0 -582 000 0 0
operatingExpenses 148M 469M 118M 123M 100M 301M 77M 197M 112M 78M
costAndExpenses 176M 564M 142M 148M 121M 366M 95M 238M 133M 95M
interestIncome 12M 0 3M 0 0 2M 0 1M 1M 944 000
interestExpense 3M 6M 3M 810 000 636 000 2M 316 000 1M 1M 944 000
depreciationAndAmortization 3M 10M 3M 3M 2M -1M -1M -7M 1M 2M
ebitda 56M 191M 48M 34M 41M 128M 35M -871 000 -63M -48M
ebitdaratio 0.256 0.256 0.188 0.257 0.27
operatingIncome 42M 166M 44M 32M 40M 124M 37M -871 000 -66M -52M
operatingIncomeRatio 0.194 0.235 0.18 0.247 0.28
totalOtherIncomeExpensesNet 8M 8M 4M 1M 923 000 -3M -2M -8M 44 000 792 000
incomeBeforeTax 50M 174M 45M 33M 41M 121M 35M -9M -66M -51M
incomeBeforeTaxRatio 0.229 0.242 0.183 0.253 0.267
incomeTaxExpense -5M 27M 10M 4M 2M -95M 118 000 301 000 80 000 62 000
netIncome 55M 147M 35M 29M 39M 216M 35M -9M -66M -51M
netIncomeRatio 0.253 0.188 0.16 0.243 0.267
eps 1.48 4.01 0.95 0.79 1.07 6.02 0.97 -0.26 -1.99 -2.14
epsdiluted 1.44 0.92 0.76 1.03 0.92
weightedAverageShsOut 37M 37M 37M 37M 36M 36M 36M 35M 33M 24M
weightedAverageShsOutDil 38M 38M 38M 38M 38M 38M 38M 35M 33M 24M
link Link Link Link Link Link
finalLink Link Link Link Link Link
filingDate 2024-02-26 2023-02-27 2022-02-25 2021-02-26 2020-03-12
fiscalYear 2023 2022 2021 2020 2019
netInterestIncome -6M 0 0 0 0
ebit 180M 123M -8M -64M -50M
nonOperatingIncomeExcludingInterest -14M 1M 7M -1M -2M
netIncomeFromContinuingOperations 147M 216M -9M -66M -51M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 147M 216M -9M -66M -51M
epsDiluted 3.85 5.7 -0.26 -1.99 -2.14

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-05-06 2023-11-06 2023-08-07 2023-05-08 2022-11-07
acceptedDate 2024-05-06 16:14:44 2024-02-26 16:06:34 2023-11-06 16:32:34 2023-08-07 16:46:48 2023-05-08 16:31:28 2023-02-27 16:08:45 2022-11-07 16:48:45 2022-02-25 16:09:03 2021-02-26 16:05:53 2020-03-12 17:02:00
calendarYear 2024 2023 2023 2023 2022
period Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
cashAndCashEquivalents 282M 328M 498M 141M 281M 157M 128M 89M 50M 139M
shortTermInvestments 748M 662M 419M 117M 136M 148M 123M 112M 152M 56M
cashAndShortTermInvestments 1 029M 991M 917M 259M 417M 304M 251M 201M 202M 195M
netReceivables 124M 115M 99M 97M 84M 71M 64M 37M 12M 7M
inventory 111M 108M 97M 92M 83M 75M 69M 43M 30M 12M
otherCurrentAssets 10M 13M 15M 9M 6M 8M 11M 5M 2M 2M
totalCurrentAssets 1 275M 1 225M 1 129M 456M 591M 459M 395M 286M 246M 217M
propertyPlantEquipmentNet 114M 99M 92M 91M 86M 81M 72M 52M 24M 14M
goodwill 40M 40M 40M 40M 0 0 0 0 0 0
intangibleAssets 92M 93M 94M 95M 0 0 0 0 0 0
goodwillAndIntangibleAssets 132M 132M 134M 134M 0 0 0 0 0 0
longTermInvestments 2M 3M 2M 3M 3M 4M 5M 6M 1M 1M
taxAssets 112M 99M 109M 95M 98M 98M 0 0 0 0
otherNonCurrentAssets 9M 8M 8M 8M 6M 5M 4M 2M 362 000 56 000
totalNonCurrentAssets 368M 341M 345M 330M 192M 187M 81M 60M 26M 15M
otherAssets 0 0 0 0 0 0 0 0 0 0
totalAssets 1 644M 1 567M 1 474M 787M 783M 646M 476M 346M 272M 232M
accountPayables 10M 9M 7M 13M 11M 7M 3M 4M 1M 3M
shortTermDebt 4M 4M 2M 2M 81M 1M 1M 7M 4M 7M
taxPayables 10M 12M 6M 4M 5M 4M 3M 1M 0 0
deferredRevenue 3M 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 69M 92M 70M 66M 50M 55M 49M 41M 20M 14M
totalCurrentLiabilities 92M 104M 78M 80M 142M 63M 54M 52M 26M 24M
longTermDebt 773M 767M 763M 57M 58M 59M 53M 40M 21M 15M
deferredRevenueNonCurrent 12M 12M 12M 12M 12M 12M 12M 12M 0 0
deferredTaxLiabilitiesNonCurrent 4M 4M 10M 10M -12M -12M 0 -24M 0 0
otherNonCurrentLiabilities 11M 11M 9M 9M 12M 12M 61M 24M 0 0
totalNonCurrentLiabilities 800M 794M 795M 89M 71M 71M 66M 52M 21M 15M
otherLiabilities 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 34M 35M 35M 0 40M 0 0 0
totalLiabilities 892M 898M 873M 170M 213M 135M 120M 104M 46M 39M
preferredStock 0 0 0 0 0 0 0 0 0 232M
commonStock 38 000 37 000 37 000 37 000 37 000 36 000 36 000 35 000 35 000 31 000
retainedEarnings 166M 110M 66M 31M 2M -37M -178M -253M -244M -178M
accumulatedOtherComprehensiveIncomeLoss -109 000 293 000 -149 000 -391 000 -367 000 -867 000 -2M -202 000 9000 35 000
othertotalStockholdersEquity 586M 535M 586M 569M 535M
totalStockholdersEquity 752M 669M 601M 617M 571M 511M 356M 242M 226M 193M
totalEquity 752M 669M 601M 617M 571M 511M 356M 242M 226M 193M
totalLiabilitiesAndStockholdersEquity 1 644M 1 474M 787M 783M 476M
minorityInterest 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 644M 1 567M 1 474M 787M 783M 646M 476M 346M 272M 232M
totalInvestments 750M 665M 419M 120M 139M 151M 127M 118M 153M 58M
totalDebt 777M 771M 765M 59M 140M 60M 55M 47M 25M 23M
netDebt 495M 442M 267M -82M -141M -96M -73M -42M -25M -116M
link Link Link Link Link Link
finalLink Link Link Link Link Link
filingDate 2024-02-26 2023-02-27 2022-02-25 2021-02-26 2020-03-12
fiscalYear 2023 2022 2021 2020 2019
accountsReceivables 0 0 0 0 0
otherReceivables 115M 71M 37M 12M 7M
prepaids 0 0 0 0 0
totalPayables 9M 7M 4M 1M 3M
otherPayables 0 0 0 0 0
accruedExpenses 0 0 0 0 0
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 558M 549M 495M 469M 371M

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV SWAV
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-05-06 2023-11-06 2023-08-07 2023-05-08 2022-11-07
acceptedDate 2024-05-06 16:14:44 2024-02-26 16:06:34 2023-11-06 16:32:34 2023-08-07 16:46:48 2023-05-08 16:31:28 2023-02-27 16:08:45 2022-11-07 16:48:45 2022-02-25 16:09:03 2021-02-26 16:05:53 2020-03-12 17:02:00
calendarYear 2024 2023 2023 2023 2022
period Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
netIncome 55M 147M 35M 29M 39M 216M 35M -9M -66M -51M
depreciationAndAmortization 3M 10M 3M 3M 2M 5M 1M 6M 3M 2M
deferredIncomeTax -13M 15M 8M 2M -547 000 -97M 0 7M 487 000 133 000
stockBasedCompensation 23M 73M 18M 17M 16M 45M 12M 27M 10M 4M
changeInWorkingCapital -25M -44M -15M -12M -22M -58M -16M -17M -20M -3M
accountsReceivables -9M -42M -3M -11M -13M -33M -5M -26M -4M -5M
inventory -3M -31M -5M -8M -8M -30M -8M -12M -17M -7M
accountsPayables 416 000 112 000 -6M -743 000 5M 2M -1M 2M -1M 1M
otherWorkingCapital -14M 29M -2M 8M -6M 3M -2M 19M 2M 7M
otherNonCashItems 186 000 -6M 1M 300 000 208 000 7M 2M 511 000 646 000 436 000
netCashProvidedByOperatingActivities 36M 196M 51M 40M 34M 118M 34M 15M -71M -48M
investmentsInPropertyPlantAndEquipment -8M -31M -7M -9M -7M -25M -7M -12M -12M -4M
acquisitionsNet 0 -94M 299M 0 0 37M 0 -26M 96M 56M
purchasesOfInvestments -401M -747M -343M -35M -21M -138M -33M -117M -168M -119M
salesMaturitiesOfInvestments 325M 247M 43M 54M 35M 101M 35M 156M 72M 64M
otherInvestingActivites -76M -299M -94M 0 0
netCashUsedForInvestingActivites -84M -306M -84M 6M -5M
debtRepayment 0 -25M 0 0 0
commonStockIssued 5M 4M 0 0 0
commonStockRepurchased -8000 -43 000 -34 000 0 3M -23 000 0 -8M -1M 0
dividendsPaid 0 0 0 0 0
otherFinancingActivites 5M 638M -96M 80M 383 000
netCashUsedProvidedByFinancingActivities 5M 613M -96M 83M 383 000
effectOfForexChangesOnCash -3M 797 000 -773 000 -322 000 792 000 -1M -1M 0 0 0
netChangeInCash -47M 172M 357M -140M 124M 67M 28M 39M -89M 100M
cashAtEndOfPeriod 283M 328M 499M 142M 283M 158M 130M 91M 52M 140M
cashAtBeginningOfPeriod 330M 157M 142M 283M 158M 91M 102M 52M 140M 40M
operatingCashFlow 36M 196M 51M 40M 34M 118M 34M 15M -71M -48M
capitalExpenditure -8M -31M -7M -9M -7M -25M -7M -12M -12M -4M
freeCashFlow 27M 165M 44M 31M 27M 93M 27M 3M -83M -52M
link Link Link Link Link Link
finalLink Link Link Link Link Link
filingDate 2024-02-26 2023-02-27 2022-02-25 2021-02-26 2020-03-12
fiscalYear 2023 2022 2021 2020 2019
otherInvestingActivities -501M -37M 26M -96M -56M
netCashProvidedByInvestingActivities -626M -62M 26M -107M -60M
netDebtIssuance 0 0 0 0 0
longTermNetDebtIssuance 0 0 0 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 0 0 0 0
netCommonStockIssuance 0 0 0 0 0
commonStockIssuance 8M 7M 6M 89M 207M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 600M 13M -2M 90M 208M
netCashProvidedByFinancingActivities 600M 13M -2M 90M 208M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-11-06 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-08 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-11-07 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2024-05-06 16:14 ET
Shockwave Medical published news for 2024 q1
SEC form 8
2024-05-06 16:05 ET
Shockwave Medical reported for 2024 q1
SEC form 8
2024-05-06 16:05 ET
Shockwave Medical published news for 2024 q1
SEC form 10
2024-05-06 00:00 ET
Shockwave Medical published news for 2024 q1
SEC form 10
2024-02-26 00:00 ET
Shockwave Medical published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Shockwave Medical reported for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Shockwave Medical published news for 2023 q4
SEC form 10
2023-11-06 16:32 ET
Shockwave Medical published news for 2023 q3
SEC form 8
2023-11-06 16:03 ET
Shockwave Medical reported for 2023 q3
SEC form 10
2023-11-06 00:00 ET
Shockwave Medical published news for 2023 q3
SEC form 10
2023-08-07 16:46 ET
Shockwave Medical reported for 2023 q2
SEC form 6
2023-08-07 16:01 ET
Shockwave Medical reported for 2023 q2
SEC form 8
2023-08-07 00:00 ET
Shockwave Medical published news for 2023 q2
SEC form 10
2023-08-07 00:00 ET
Shockwave Medical published news for 2023 q2
SEC form 6
2023-06-14 16:16 ET
Shockwave Medical published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
Shockwave Medical published news for 2023 q1
SEC form 10
2023-05-08 00:00 ET
Shockwave Medical published news for 2023 q1
SEC form 6
2023-04-11 08:08 ET
Shockwave Medical published news for 2023 q1
SEC form 10
2023-02-27 16:08 ET
Shockwave Medical reported for 2022 q4
SEC form 10
2023-02-27 00:00 ET
Shockwave Medical reported for 2022 q4
SEC form 6
2023-02-16 16:02 ET
Shockwave Medical published news for 2022 q4
SEC form 8
2023-02-16 00:00 ET
Shockwave Medical reported for 2022 q4
SEC form 6
2023-01-17 08:08 ET
Shockwave Medical published news for 2022 q4
SEC form 6
2022-12-23 16:15 ET
Shockwave Medical published news for 2022 q3
SEC form 10
2022-11-07 16:48 ET
Shockwave Medical reported for 2022 q3
SEC form 6
2022-11-07 16:05 ET
Shockwave Medical published news for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Shockwave Medical reported for 2022 q3
SEC form 10
2022-11-07 00:00 ET
Shockwave Medical reported for 2022 q3
SEC form 6
2022-10-20 16:52 ET
Shockwave Medical published news for 2022 q3
SEC form 10
2022-08-08 16:45 ET
Shockwave Medical reported for 2022 q2
SEC form 6
2022-08-08 16:06 ET
Shockwave Medical published news for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Shockwave Medical reported for 2022 q2
SEC form 8
2022-08-08 00:00 ET
Shockwave Medical reported for 2022 q2
SEC form 6
2022-06-24 16:40 ET
Shockwave Medical published news for 2022 q1
SEC form 10
2022-05-09 16:45 ET
Shockwave Medical reported for 2022 q1
SEC form 6
2022-05-09 16:03 ET
Shockwave Medical published news for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Shockwave Medical reported for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Shockwave Medical reported for 2022 q1
SEC form 6
2022-04-29 16:08 ET
Shockwave Medical published news for 2022 q1
SEC form 6
2022-03-30 16:47 ET
Shockwave Medical published news for 2021 q4
SEC form 10
2022-02-25 16:09 ET
Shockwave Medical published news for 2021 q4
SEC form 10
2022-02-25 00:00 ET
Shockwave Medical published news for 2021 q4
SEC form 6
2022-02-22 16:08 ET
Shockwave Medical published news for 2021 q4
SEC form 6
2022-02-17 16:05 ET
Shockwave Medical published news for 2021 q4
SEC form 8
2022-02-17 00:00 ET
Shockwave Medical published news for 2021 q4
SEC form 10
2021-11-08 17:21 ET
Shockwave Medical published news for 2021 q3
SEC form 6
2021-11-08 16:05 ET
Shockwave Medical published news for 2021 q3
SEC form 8
2021-11-08 00:00 ET
Shockwave Medical published news for 2021 q3
SEC form 10
2021-11-08 00:00 ET
Shockwave Medical published news for 2021 q3
SEC form 6
2021-09-28 17:42 ET
Shockwave Medical published news for 2021 q2
SEC form 10
2021-08-09 16:06 ET
Shockwave Medical published news for 2021 q2
SEC form 6
2021-08-09 07:30 ET
Shockwave Medical published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
Shockwave Medical published news for 2021 q2
SEC form 8
2021-08-09 00:00 ET
Shockwave Medical published news for 2021 q2
SEC form 6
2021-06-29 17:28 ET
Shockwave Medical published news for 2021 q1
SEC form 10
2021-05-10 17:10 ET
Shockwave Medical published news for 2021 q1
SEC form 6
2021-05-10 16:05 ET
Shockwave Medical published news for 2021 q1
SEC form 8
2021-05-10 00:00 ET
Shockwave Medical published news for 2021 q1
SEC form 10
2021-05-10 00:00 ET
Shockwave Medical published news for 2021 q1
SEC form 6
2021-04-29 15:54 ET
Shockwave Medical published news for 2021 q1
SEC form 6
2021-03-30 17:14 ET
Shockwave Medical published news for 2020 q4
SEC form 6
2021-03-26 20:37 ET
Shockwave Medical published news for 2020 q4
SEC form 6
2021-03-25 16:30 ET
Shockwave Medical published news for 2020 q4
SEC form 10
2021-02-26 16:05 ET
Shockwave Medical published news for 2020 q4
SEC form 6
2021-02-17 21:26 ET
Shockwave Medical published news for 2020 q4
SEC form 6
2021-02-17 16:05 ET
Shockwave Medical published news for 2020 q4
SEC form 6
2020-11-18 21:33 ET
Shockwave Medical published news for 2020 q3
SEC form 6
2020-11-18 21:08 ET
Shockwave Medical published news for 2020 q3
SEC form 6
2020-11-17 18:18 ET
Shockwave Medical published news for 2020 q3
SEC form 6
2020-11-12 20:15 ET
Shockwave Medical published news for 2020 q3
SEC form 6
2020-11-10 16:30 ET
Shockwave Medical published news for 2020 q3
SEC form 10
2020-11-10 16:00 ET
Shockwave Medical published news for 2020 q3
SEC form 6
2020-11-09 16:39 ET
Shockwave Medical published news for 2020 q3